Artykuł w czasopiśmie
Brak miniatury
Licencja
CC-BYCC-BY - Uznanie autorstwa
 

Metastatic tumor burden and loci as predictors of first line sunitinib treatment efficacy in patients with renal cell carcinoma.

Uproszczony widok
cris.lastimport.scopus2024-02-12T20:07:21Z
dc.affiliationUniwersytet Warszawski
dc.contributor.authorDendek, Cezary
dc.contributor.authorKorniluk, Jan
dc.contributor.authorBrodziak, Anna
dc.contributor.authorLABOCHKA, DOMINIKA
dc.contributor.authorSzczylik, Cezary
dc.contributor.authorCzarnecka, Anna M
dc.contributor.authorSobczuk, Paweł
dc.contributor.authorBartnik, Ewa
dc.date.accessioned2024-01-25T11:28:08Z
dc.date.available2024-01-25T11:28:08Z
dc.date.copyright2019-05-27
dc.date.issued2019
dc.description.accesstimeAT_PUBLICATION
dc.description.financeNie dotyczy
dc.description.number1
dc.description.versionFINAL_PUBLISHED
dc.description.volume9
dc.identifier.doi10.1038/S41598-019-44226-Y
dc.identifier.issn2045-2322
dc.identifier.urihttps://repozytorium.uw.edu.pl//handle/item/112350
dc.identifier.weblinkhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533291/
dc.languageeng
dc.pbn.affiliationbiological sciences
dc.relation.ispartofScientific Reports
dc.relation.pages7754, 1-10
dc.rightsCC-BY
dc.sciencecloudnosend
dc.subject.enCarcinoma Renal Cell - drug therapy
dc.subject.enIndoles - therapeutic use
dc.subject.enPyrroles - therapeutic use
dc.subject.enNeoplasm metastasis
dc.subject.enMedical Oncology
dc.titleMetastatic tumor burden and loci as predictors of first line sunitinib treatment efficacy in patients with renal cell carcinoma.
dc.typeJournalArticle
dspace.entity.typePublication